How long does it take for resistance to lvosidenib to develop?

Ivosidenib is a small molecule, oral inhibitor of mutant cytosolic isocitrate dehydrogenase 1 (IDH1) developed by Agios Pharmaceuticals for the treatment of cancer in patients with IDH1 mutations. IDH1Mutated forms of the enzyme produce the metabolite 2-hydroxyglutarate(2-HG), which is thought to play a role in the development and progression of acute myeloid leukemia(AML), gliomas, and other cancers. Elevated 2-HG levels interfere with cellular metabolism and epigenetic regulation, leading to tumorigenesis. Ivosidenibtargets the IDH1 metabolic pathway to prevent the accumulation of the tumor metabolite 2-HG. Ivonib was approved for the first time in the United States for the treatment of patients with relapsed or refractory AML that is susceptible to IDH1 mutations.

You should not use it if you are allergic toivonibbefore taking it. Please tell your doctor if you have::heart disease;longQTSyndrome: Nerve problems; electrolyte imbalance (such as low levels of potassium, sodium or magnesium in the blood); cirrhosis or liver disease or kidney disease. Ivosidenibcan decrease the effectiveness of hormonal birth control pills, including birth control pills, injections, implants, skin patches, and vaginal rings. Use barrier contraception to prevent pregnancy:Condoms, diaphragms, cervical caps, or contraceptive sponges. Pregnancy is less likely when either the mother or father uses ivosidenib. Women should still use birth control to prevent pregnancy because the medication can harm an unborn baby.

Do not breastfeed while usingivosidenib for at least1 months after the last dose. If you want to get more high-quality information, you can contact Yaode. Yaode will do its best to learn more about high-quality overseas drugs for you.